Literature DB >> 19765780

Failure of d-psicose absorbed in the small intestine to metabolize into energy and its low large intestinal fermentability in humans.

Tetsuo Iida1, Noriko Hayashi, Takako Yamada, Yuko Yoshikawa, Shoko Miyazato, Yuka Kishimoto, Kazuhiro Okuma, Masaaki Tokuda, Ken Izumori.   

Abstract

Experiments with rats have produced data on the metabolism and energy value of d-psicose; however, no such data have been obtained in humans. The authors assessed the availability of d-psicose absorbed in the small intestine by measuring carbohydrate energy expenditure (CEE) by indirect calorimetry. They measured the urinary excretion rate by quantifying d-psicose in urine for 48 hours. To examine d-psicose fermentation in the large intestine, the authors measured breath hydrogen gas and fermentability using 35 strains of intestinal bacteria. Six healthy subjects participated in the CEE test, and 14 participated in breath hydrogen gas and urine tests. d-Psicose fermentation subsequent to an 8-week adaptation period was also assessed by measuring hydrogen gas in 8 subjects. d-Psicose absorbed in the small intestine was not metabolized into energy, unlike glucose, because CEE did not increase within 3 hours of d-psicose ingestion (0.35 g/kg body weight [BW]). The accumulated d-psicose urinary excretion rates were around 70% for 0.34, 0.17, and 0.08 g/kg BW of ingested d-psicose. Low d-psicose fermentability was observed in intestinal bacteria and breath hydrogen gas tests, in which fructooligosaccharide (0.34, 0.17, and 0.08 g/kg BW) was used as a positive control because its available energy is known to be 8.4 kJ/g. Based on the results of the plot of breath hydrogen concentration vs calories ingested, the energy value of d-psicose was expected to be less than 1.6 kJ/g. Incremental d-psicose fermentability subsequent to an adaptation period was not observed. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765780     DOI: 10.1016/j.metabol.2009.07.018

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  D-Allulose enhances uptake of HDL-cholesterol into rat's primary hepatocyte via SR-B1.

Authors:  Akane Kanasaki; Tetsuo Iida; Koji Murao; Bungo Shirouchi; Masao Sato
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

2.  GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.

Authors:  Yusaku Iwasaki; Mio Sendo; Katsuya Dezaki; Tohru Hira; Takehiro Sato; Masanori Nakata; Chayon Goswami; Ryohei Aoki; Takeshi Arai; Parmila Kumari; Masaki Hayakawa; Chiaki Masuda; Takashi Okada; Hiroshi Hara; Daniel J Drucker; Yuichiro Yamada; Masaaki Tokuda; Toshihiko Yada
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919

3.  Adaptive Steered Molecular Dynamics Combined With Protein Structure Networks Revealing the Mechanism of Y68I/G109P Mutations That Enhance the Catalytic Activity of D-psicose 3-Epimerase From Clostridium Bolteae.

Authors:  Jingxuan Zhu; Yi Li; Jinzhi Wang; Zhengfei Yu; Ye Liu; Yi Tong; Weiwei Han
Journal:  Front Chem       Date:  2018-09-24       Impact factor: 5.221

4.  Comparative Effects of Allulose, Fructose, and Glucose on the Small Intestine.

Authors:  Takuji Suzuki; Yuki Sato; Sumire Kadoya; Takumi Takahashi; Moeko Otomo; Hanna Kobayashi; Kai Aoki; Mai Kantake; Maika Sugiyama; Ronaldo P Ferraris
Journal:  Nutrients       Date:  2022-08-07       Impact factor: 6.706

5.  Single oral dose safety of D-allulose in dogs.

Authors:  Naohito Nishii; Toru Nomizo; Satoshi Takashima; Tatsuya Matsubara; Masaaki Tokuda; Hitoshi Kitagawa
Journal:  J Vet Med Sci       Date:  2016-03-14       Impact factor: 1.267

6.  A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.

Authors:  Catherine R Braunstein; Jarvis C Noronha; Andrea J Glenn; Effie Viguiliouk; Rebecca Noseworthy; Tauseef A Khan; Fei Au-Yeung; Sonia Blanco Mejia; Thomas M S Wolever; Robert G Josse; Cyril W C Kendall; John L Sievenpiper
Journal:  Nutrients       Date:  2018-06-09       Impact factor: 5.717

7.  Identification of Pathogenicity-Associated Loci in Klebsiella pneumoniae from Hospitalized Patients.

Authors:  Rebekah M Martin; Jie Cao; Weisheng Wu; Lili Zhao; David M Manthei; Ali Pirani; Evan Snitkin; Preeti N Malani; Krishna Rao; Michael A Bachman
Journal:  mSystems       Date:  2018-06-26       Impact factor: 6.496

8.  Highly efficient production of Clostridium cellulolyticum H10 D-psicose 3-epimerase in Bacillus subtilis and use of these cells to produce D-psicose.

Authors:  Lingqia Su; Fan Sun; Zhanzhi Liu; Kang Zhang; Jing Wu
Journal:  Microb Cell Fact       Date:  2018-11-28       Impact factor: 5.328

9.  Metabolic Stability of D-Allulose in Biorelevant Media and Hepatocytes: Comparison with Fructose and Erythritol.

Authors:  Han-Joo Maeng; Jin-Ha Yoon; Kwang-Hoon Chun; Sung Tae Kim; Dong-Jin Jang; Ji-Eun Park; Yang Hee Kim; Seong-Bo Kim; Yu Chul Kim
Journal:  Foods       Date:  2019-10-01

10.  d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.

Authors:  Misato Niibo; Akane Kanasaki; Tetsuo Iida; Keisuke Ohnishi; Taro Ozaki; Kazuya Akimitsu; Tetsuo Minamino
Journal:  PLoS One       Date:  2022-01-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.